Chatellier D, Jourdain M, Mangalaboyi J, Ader F, Chopin C, Derambure P, Fourrier F
Service de Réanimation Polyvalente, Hôpital Roger Salengro, CHRU Université Lille 2, 59037 Lille, France.
Intensive Care Med. 2002 Feb;28(2):214-7. doi: 10.1007/s00134-001-1170-9. Epub 2001 Dec 4.
To describe five new cases of life-threatening cefepime-induced neurotoxicity observed in a 2-year period.
A university intensive care unit.
Five patients recently treated with cefepime, admitted for seizures and coma. All suffered from acute renal failure, induced by sepsis and combined aminoside therapy, or by cefepime itself in one case.
All patients underwent hemodialysis, which led to complete neurological improvement in four of them. One patient remained comatose and subsequently died.
Blood and CSF cefepime levels were measured by high performance liquid chromatography before and after hemodialysis.
The frequency of cefepime-induced neurotoxicity is probably underestimated. Monitoring of renal function and close neurological survey in treated patients should allow an early diagnosis of this complication. Urgent hemodialysis seems the best therapeutic method to obtain a rapid neurological improvement.
描述在两年期间观察到的5例由头孢吡肟引起的危及生命的神经毒性新病例。
一所大学的重症监护病房。
5例近期接受头孢吡肟治疗的患者,因癫痫发作和昏迷入院。所有患者均患有急性肾衰竭,其中4例由败血症和联合使用氨基糖苷类药物治疗引起,1例由头孢吡肟本身引起。
所有患者均接受血液透析,其中4例患者神经功能完全改善。1例患者仍昏迷,随后死亡。
在血液透析前后,采用高效液相色谱法测量血液和脑脊液中头孢吡肟的水平。
头孢吡肟引起的神经毒性发生率可能被低估。对接受治疗的患者监测肾功能并密切进行神经学检查,应能早期诊断这种并发症。紧急血液透析似乎是实现神经功能快速改善的最佳治疗方法。